scholarly article | Q13442814 |
P50 | author | Juan C Zapata | Q63378737 |
Igor S Lukashevich | Q89978578 | ||
P2093 | author name string | Oswald R Crasta | |
Otto Folkerts | |||
Zhangjun Fei | |||
Maria S Salvato | |||
Marti Jett | |||
Rasha Hammamieh | |||
Bruno Sobral | |||
Joseph Bryant | |||
C David Pauza | |||
Harry Davis | |||
Mark Swindells | |||
Mahmoud M Djavani | |||
P2860 | cites work | Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus | Q24292060 |
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector | Q24316159 | ||
Expression of the interferon-alpha/beta-inducible bovine Mx1 dynamin interferes with replication of rabies virus | Q24337511 | ||
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements | Q24597089 | ||
On the front lines of Lassa fever | Q24599583 | ||
A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy | Q24675684 | ||
Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase | Q24792264 | ||
Identification and utilization of inter-species conserved (ISC) probesets on Affymetrix human GeneChip platforms for the optimization of the assessment of expression patterns in non human primate (NHP) samples | Q24793314 | ||
Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA Replication | Q27470314 | ||
Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies | Q28206468 | ||
Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88 | Q28646151 | ||
affy--analysis of Affymetrix GeneChip data at the probe level | Q29547353 | ||
Hematologic dysfunction in Lassa fever | Q33448183 | ||
Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines | Q33755013 | ||
The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus. | Q33781829 | ||
The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner | Q33801521 | ||
Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events | Q33839711 | ||
Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus | Q33842651 | ||
Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs | Q33870381 | ||
Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1 | Q34302223 | ||
LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration | Q34338137 | ||
Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells | Q34341267 | ||
Do pathogens accelerate atherosclerosis? | Q34389205 | ||
Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells | Q34424726 | ||
Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence | Q34434866 | ||
Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. | Q34467311 | ||
Interleukin-1, neuroinflammation, and Alzheimer's disease | Q34469514 | ||
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus | Q34647754 | ||
Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus. | Q35024355 | ||
Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections | Q35101515 | ||
Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics | Q35139200 | ||
Timed appearance of lymphocytic choriomeningitis virus after gastric inoculation of mice | Q35763835 | ||
Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2 | Q36369190 | ||
Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus. | Q36681272 | ||
Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus | Q36701093 | ||
Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever. | Q36925354 | ||
Myristoylation of the RING finger Z protein is essential for arenavirus budding | Q37568060 | ||
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model | Q37585469 | ||
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. | Q37596973 | ||
Transcriptional response of a common permissive cell type to infection by two diverse alphaherpesviruses | Q38343679 | ||
Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression | Q38571526 | ||
Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted | Q38663795 | ||
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. | Q38973017 | ||
Alterations in NF-kappaB and RBP-Jkappa by arenavirus infection of macrophages in vitro and in vivo | Q39002185 | ||
Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis | Q39683810 | ||
T-Cell-Mediated Immunopathology in Viral Infections | Q39943334 | ||
Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer. | Q40254226 | ||
Up-regulation of astrocyte cyclooxygenase-2, CCAAT/enhancer-binding protein-homology protein, glucose-related protein 78, eukaryotic initiation factor 2 alpha, and c-Jun N-terminal kinase by a neurovirulent murine retrovirus | Q40394829 | ||
Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins | Q40400483 | ||
Identification of differentially activated cell-signaling networks associated with pichinde virus pathogenesis by using systems kinomics. | Q40462980 | ||
Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. | Q40478465 | ||
Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection | Q40552244 | ||
The use of interferon for emergency prophylaxis of marburg hemorrhagic fever in monkeys. | Q40593915 | ||
Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever | Q40602416 | ||
Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. | Q40693235 | ||
A plasma inhibitor of platelet aggregation in patients with Lassa fever | Q40772339 | ||
Experimental studies of arenaviral hemorrhagic fevers | Q40802232 | ||
Lassa virus hepatitis: a study of fatal Lassa fever in humans | Q40809779 | ||
Pathogenicity of the Lassa virus for laboratory mice | Q40815386 | ||
Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways. | Q40847997 | ||
Interferon induction and/or production and its suppression by influenza A viruses | Q41058470 | ||
Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus | Q41847342 | ||
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice | Q42004309 | ||
Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. | Q45083421 | ||
COX-2 inhibitors--lessons in drug safety | Q45267551 | ||
Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy. | Q45495234 | ||
CD8 T cell responses to lymphocytic choriomeningitis virus in early growth response gene 1-deficient mice | Q45592005 | ||
Murine hepatitis caused by lymphocytic choriomeningitis virus. I. The hepatic lesions. | Q45779139 | ||
Infection of guinea pigs with two strains of lymphocytic choriomeningitis virus. | Q45852113 | ||
Factors affecting plaque formation by Lassa virus in Vero cells | Q50240790 | ||
CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus. | Q53629031 | ||
CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection | Q56798247 | ||
Adenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2 | Q64379203 | ||
EXPERIMENTAL INHALATION INFECTION OF MONKEYS OF THE MACACUS CYNOMOLGUS AND MACACUS RHESUS SPECIES WITH THE VIRUS OF LYMPHOCYTIC CHORIOMENINGITIS (WE) | Q76568244 | ||
A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan | Q77198723 | ||
Lassa fever | Q78037746 | ||
A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response | Q80542447 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Lassa fever | Q706845 |
Lassa virus | Q1806636 | ||
P304 | page(s) | 7960-7973 | |
P577 | publication date | 2007-05-23 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Early blood profiles of virus infection in a monkey model for Lassa fever | |
P478 | volume | 81 |
Q30250910 | A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies. |
Q41922365 | A Primate Model for Viral Hemorrhagic Fever |
Q34647510 | A systems biology starter kit for arenaviruses |
Q37434945 | A systems biology view of cancer |
Q26823627 | Advanced vaccine candidates for Lassa fever |
Q36387183 | Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes |
Q36698306 | An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity. |
Q37033404 | Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infection |
Q90190052 | Animal Models of Lassa Fever |
Q38064279 | Arenavirus evasion of host anti-viral responses |
Q40285838 | Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. |
Q33905046 | Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics |
Q61817661 | Clinical Characterization of Host Response to Simian Hemorrhagic Fever Virus Infection in Permissive and Refractory Hosts: A Model for Determining Mechanisms of VHF Pathogenesis |
Q33959989 | Comparative pathogenesis and systems biology for biodefense virus vaccine development |
Q35076680 | Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques |
Q41922464 | Diagnostics for Lassa Fever: Detecting Host Antibody Responses. |
Q37463214 | Fibroblastic reticular cells and their role in viral hemorrhagic fevers |
Q40397175 | Gene expression in primate liver during viral hemorrhagic fever |
Q35248863 | Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man |
Q34266468 | Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses |
Q38061425 | Host cell factors as antiviral targets in arenavirus infection |
Q58109386 | Improving the Breadth of the Host's Immune Response to Lassa Virus |
Q34515519 | Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection |
Q37912497 | Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever. |
Q37103536 | Macaque models of human infectious disease |
Q38615950 | Meta-analysis of high-throughput datasets reveals cellular responses following hemorrhagic fever virus infection. |
Q33524893 | Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection |
Q34625899 | Pathogenesis of arenavirus hemorrhagic fevers |
Q36155495 | Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro |
Q37464889 | Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever |
Q33656417 | Proteomic analysis of Pichindé virus infection identifies differential expression of prothymosin-alpha |
Q33963386 | Reactive astrogliosis in response to hemorrhagic fever virus: microarray profile of Junin virus-infected human astrocytes |
Q33549960 | Response network analysis of differential gene expression in human epithelial lung cells during avian influenza infections |
Q36970552 | Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates |
Q27666703 | Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression |
Q63246534 | T-Cell Response to Viral Hemorrhagic Fevers |
Q36806151 | The sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infection |
Q27305228 | Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure |
Q34999818 | Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate |
Q37884343 | Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling. |
Q38823264 | Vaccine platforms to control Lassa fever |
Q92815358 | Viral Strain Determines Disease Symptoms, Pathology, and Immune Response in Neonatal Rats with Lymphocytic Choriomeningitis Virus Infection |
Search more.